SCHEMBL9554202

SCHEMBL9554202

CCCCC(=O)n1c(Cl)c(CCCC)n(Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)c1=O

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 12/20 0.44
AGTR2 P50052 11/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9554925 0.97 AGTR1 (0.44) AGTR1AGTR2
SCHEMBL9554499 0.97 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9553519 0.94 AGTR1 (0.44) AGTR1AGTR2
SCHEMBL9534365 0.93 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL9554168 0.92 AGTR1 (0.44) AGTR1AGTR2
SCHEMBL9530097 0.92 AGTR1 (0.44) AGTR1AGTR2
SCHEMBL9530428 0.91 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL9529909 0.91 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL9554220 0.90 AGTR1 (0.46) AGTR1AGTR2
SCHEMBL9553888 0.90 AGTR1 (0.43) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed